Entresto and Libido decreased - a phase IV clinical study of FDA data
Libido decreased is found among people who take Entresto, especially for people who are male, 40-49 old.
The phase IV clinical study analyzes which people take Entresto and have Libido decreased. It is created by eHealthMe based on reports of 68,359 people who have side effects when taking Entresto from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
68,359 people reported to have side effects when taking Entresto.
Among them, 11 people (0.02%) have Libido decreased.
What is Entresto?
Entresto has active ingredients of sacubitril; valsartan. eHealthMe is studying from 68,552 Entresto users for its effectiveness, alternative drugs and more.
What is Libido decreased?
Libido decreased (loss of interest in sex) is found to be associated with 1,449 drugs and 886 conditions by eHealthMe.
Number of Entresto and Libido decreased reports submitted per year:
Gender of people who have Libido decreased when taking Entresto *:
- female: 0.0 %
- male: 100 %
Age of people who have Libido decreased when taking Entresto *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common drugs people take besides Entresto *:
- Lasix: 3 people, 27.27%
- Baby Aspirin: 3 people, 27.27%
- Xanax: 1 person, 9.09%
- Potassium: 1 person, 9.09%
- Plavix: 1 person, 9.09%
- Cymbalta: 1 person, 9.09%
- Cialis: 1 person, 9.09%
- Ambien: 1 person, 9.09%
- Adderall: 1 person, 9.09%
Common side effects people have besides Libido decreased *:
- Breathing Difficulty: 5 people, 45.45%
- Fatigue (feeling of tiredness): 5 people, 45.45%
- Weight Increased: 4 people, 36.36%
- Blood Pressure Diastolic Decreased: 3 people, 27.27%
- Cough: 3 people, 27.27%
- Ejection Fraction Abnormal (abnormality in percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat): 3 people, 27.27%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 27.27%
- Heart Rate Increased: 2 people, 18.18%
- Dizziness: 2 people, 18.18%
- Weight Decreased: 2 people, 18.18%
Common conditions people have *:
- Cardiac Failure: 4 people, 36.36%
* Approximation only. Some reports may have incomplete information.
Do you take Entresto and have Libido decreased?Check whether Libido decreased is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Entresto:
- Entresto (68,552 reports)
Libido decreased treatments and more:
- Libido decreased (14,413 reports)
COVID vaccines that are related to Libido decreased:
- Libido decreased in Moderna COVID Vaccine
- Libido decreased in Pfizer BioNTech Covid Vaccine
- Libido decreased in Johnson and Johnson Covid Vaccine
How severe was Libido decreased and when was it recovered:
Expand to all the drugs that have ingredients of sacubitril; valsartan:
Common drugs associated with Libido decreased:
All the drugs that are associated with Libido decreased:
- Libido decreased (1,449 drugs)
Common conditions associated with Libido decreased:
All the conditions that are associated with Libido decreased:
- Libido decreased (886 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on sacubitril; valsartan (the active ingredients of Entresto) and Entresto (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Metoprolol Succinate and Valproate Sodium drug interaction - 9 seconds ago
- Acitretin and Hypokalemia - 11 seconds ago
- Xarelto and Myoglobin Blood Increased - 17 seconds ago
- Fluconazole and Serum Ferritin Decreased - 17 seconds ago
- Linseed Oil and Acetaminophen drug interaction - 21 seconds ago